INS and diabetes mellitus: Three DM-INI patients experienced worse glycemic control, unrelated to INI, as reflected in the insignificant differences between DM-INI and DM-Placebo for changes in plasma insulin, HOMA-IR, fasting glucose, normal walking, and dual-task walking.